Pathology of erection
- PMID: 12834029
Pathology of erection
Abstract
Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection which is adequate for satisfactory sexual intercourse. It is a significant male health problem affecting approximately 150 million men worldwide. This value is expected to more than double by the year 2025. The incidence of ED increases sharply with age since it is a common cross-cultural denominator, affecting 19 to 64% of men aged 40 to 80 years, both in developing and industrialized countries. Epidemiological studies may underestimate the true dimensions of the problem because of the embarrassment or stigma that is associated with ED. Men with ED may experience diminished self-image and self-esteem, anxiety and fears of rejection, and even depression as psychogenic factors. Pathologic conditions which are commonly encountered in the ageing male (diabetes, hypertension, atherosclerosis, cardiovascular disease, etc) as well as chronic diseases (arthritis, renal and hepatic failure, pulmonary disease) represent a frequent cause of organic ED and are often treated with medications that can interfere with sexual function at central and/or peripheral level. In addition, incorrect lifestyle--i.e. obesity, cigarette smoking, alcohol or drug abuse--may all contribute to the onset of ED. Finally, trauma or surgery affecting either the nervous system or interfering with the blood supply to the penis are associated with increased incidence of ED.
Similar articles
-
Erectile dysfunction and its relationship with cardiovascular risk factors and disease.Saudi Med J. 2009 Feb;30(2):184-90. Saudi Med J. 2009. PMID: 19198703 Review.
-
[Clinical and diagnostic approach to erectile dysfunction].Ann Ital Med Int. 2003 Oct-Dec;18(4):204-18. Ann Ital Med Int. 2003. PMID: 14971709 Review. Italian.
-
Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age.Curr Med Res Opin. 2006 May;22(5):939-48. doi: 10.1185/030079906X104704. Curr Med Res Opin. 2006. PMID: 16709315 Clinical Trial.
-
Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS).Eur Urol. 2004 May;45(5):628-33. doi: 10.1016/j.eururo.2003.11.020. Eur Urol. 2004. PMID: 15082206
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
Cited by
-
Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.J Endocrinol Invest. 2004 Feb;27(2):192-206. doi: 10.1007/BF03346268. J Endocrinol Invest. 2004. PMID: 15129818 Review.
-
Abnormal brain structure as a potential biomarker for venous erectile dysfunction: evidence from multimodal MRI and machine learning.Eur Radiol. 2018 Sep;28(9):3789-3800. doi: 10.1007/s00330-018-5365-7. Epub 2018 Mar 29. Eur Radiol. 2018. PMID: 29600478
Publication types
MeSH terms
LinkOut - more resources
Medical